Clinical utility of carbonic anhydrase IX in diagnosing pleural mesothelioma

Mesothelioma is an aggressive tumor with a poor prognosis. Histological diagnosis of mesothelioma using limited tissue samples can be challenging.

Novel Drug for Chronic Inducible Urticaria Delivers in Mid-Stage Trial

BOSTON — Treatment with an investigational anti-KIT monoclonal antibody induced clinically meaningful responses in the two most common forms of chronic inducible urticaria, a dose-ranging

October 30, 2024

New study highlights the need for advanced pneumococcal vaccines in the wake of pre-COVID data

The risk factors associated with CAP caused by serotypes in the different pneumococcal vaccines.

December 14, 2023

Semaglutide May Boost Taste Sensitivity

BOSTON — Once-weekly semaglutide (Ozempic, Wegovy) improved taste sensitivity, changed gene expression in the tongue linked to taste perception, and changed brain activity in response

June 3, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.